Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 27, Numéro 3, Mai 2018
Infectieux
Page(s) 228 - 238
Section Mise au point / Update
DOI https://doi.org/10.3166/rea-2018-0051
Publié en ligne 4 juillet 2018
  • Tatem AJ, Jia P, Ordanovich D, Falkner M, Huang Z, Howes R, Hay SI, Gething PW, Smith DL, (2017) The geography of imported malaria to non-endemic countries: a meta-analysis of nationally reported statistics. Lancet Infect Dis 17: 98–107 [CrossRef] [PubMed] [Google Scholar]
  • Société de pathologie infectieuse de langue française, Collège des universitaires de maladies infectieuses et tropicales, Société française de médecine des armées, Société française de parasitologie, Société française de pédiatrie, Société française de médecine des voyages, Société de pathologie exotique, Société de réanimation de langue française, (2018) Management and prevention of imported malaria (Revision 2017 of the 2007 Recommendations for clinical practice). Med Mal Infect (In Press) [Google Scholar]
  • Société de pathologie infectieuse de langue française, Collège des universitaires de maladies infectieuses et tropicales, Société française de médecine des armées, Société française de parasitologie, Société française de pédiatrie, Société de médecine des voyages, Société de pathologie exotique, Société de réanimation de langue française, (2008) Management and prevention of imported Plasmodium falciparum malaria (Revision 2007 of the 1999 Consensus Conference). Med Mal Infect 38: 68–117 (Long text in French) [CrossRef] [PubMed] [Google Scholar]
  • World Health Organization, (2014) Severe malaria. Trop Med Int Health 19: 7–131 [Google Scholar]
  • Kurth F, Develoux M, Mechain M, Malvy D, Clerinx J, Antinori S, Gjørup IE, Gascon J, Mørch K, Nicastri E, Ramharter M, Bartoloni A, Visser L, Rolling T, Zanger P, Calleri G, Salas-Coronas J, Nielsen H, Just-Nübling G, Neumayr A, Hachfeld A, Schmid ML, Antonini P, Lingscheid T, Kern P, Kapaun A, da Cunha JS, Pongratz P, Soriano-Arandes A, Schunk M, Suttorp N, Hatz C, Zoller T, (2017) Severe malaria in Europe: an 8-year multicentre observational study. Malar J 16: 57 [CrossRef] [PubMed] [Google Scholar]
  • Bruneel F, Tubach F, Mira JP, Houze S, Gibot S, Huisse MG, Megarbane B, Choquet C, Corne P, Peytel E, Villers D, Camus C, Bouchaud O, Caumes E, Girard PM, Simon F, Kalloumeh A, Roy C, Durand R, Le Bras J, Matheron S, Wolff M; PALUREA Study Group, (2016) Imported falciparum malaria in adults: hostand parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study. Intensive Care Med 42: 1588–1596 [CrossRef] [PubMed] [Google Scholar]
  • Roussel C, Caumes E, Thellier M, Ndour PA, Buffet PA, Jauréguiberry S, (2017) Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications. J Travel Med 24(2) [Google Scholar]
  • Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le Bras J, Wolff M ; Severe Imported Malaria in Adults (SIMA) Study Group, (2010) Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PloS One 5: e13236 [CrossRef] [PubMed] [Google Scholar]
  • Bruneel F, Hocqueloux L, Alberti C, Wolff M, Chevret S, Bédos JP, Durand R, Le Bras J, Régnier B, Vachon F, (2003) The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am J Respir Crit Care Med 167: 684–689 [CrossRef] [PubMed] [Google Scholar]
  • Mühlberger N, Jelinek T, Behrens RH, Gjørup I, Coulaud JP, Clerinx J, Puente S, Burchard G, Gascon J, Grobusch MP, Weitzel T, Zoller T, Kollaritsch H, Beran J, Iversen J, Hatz C, Schmid ML, Björkman A, Fleischer K, Bisoffi Z, Guggemos W, Knobloch J, Matteelli A, Schulze MH, Laferl H, Kapaun A, McWhinney P, Lopez-Velez R, Fätkenheuer G, Kern P, Zieger BW, Kotlowski A, Fry G, Cuadros J, Myrvang B, TropNetEurop, Surveillance importierter Infektionen in Deutschland Surveillance Networks, (2003) Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis 36: 990–995 [CrossRef] [PubMed] [Google Scholar]
  • Checkley AM, Smith A, Smith V, Blaze M, Bradley D, Chiodini PL, Whitty CJ, (2012) Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study. BMJ 344: e2116 [Google Scholar]
  • Kurth F, Develoux M, Mechain M, Clerinx J, Antinori S, Gjørup IE, Gascon J, Mørch K, Nicastri E, Ramharter M, Bartoloni A, Visser L, Rolling T, Zanger P, Calleri G, Salas-Coronas J, Nielsen H, Just-Nübling G, Neumayr A, Hachfeld A, Schmid ML, Antonini P, Pongratz P, Kern P, Saraiva da Cunha J, Soriano-Arandes A, Schunk M, Suttorp N, Hatz C, Zoller T; TropNet Severe Malaria Investigator Group, (2015) Intravenous artesunate reduces parasite clearance time, duration of intensive care, and hospital treatment in patients with severe malaria in Europe: The TropNet Severe Malaria Study. Clin Infect Dis 61: 1441–1444 [CrossRef] [PubMed] [Google Scholar]
  • Jauréguiberry S, Ndour PA, Roussel C, Ader F, Safeukui I, Nguyen M, Biligui S, Ciceron L, Mouri O, Kendjo E, Bricaire F, Vray M, Angoulvant A, Mayaux J, Haldar K, Mazier D, Danis M, Caumes E, Thellier M, Buffet P, French Artesunate Working Group, (2014) Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins. Blood 124: 167–175 [Google Scholar]
  • Zoller T, Junghanss T, Kapaun A, Gjorup I, Richter J, Hugo-Persson M, Mørch K, Foroutan B, Suttorp N, Yürek S, Flick H, (2011) Intravenous artesunate for severe malaria in travelers, Europe. Emerg Infect Dis 17: 771–777 [Google Scholar]
  • Kreeftmeijer-Vegter AR, van Genderen PJ, Visser LG, Bierman WF, Clerinx J, van Veldhuizen CK, de Vries PJ, (2012) Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium. Malar J 11: 102 [CrossRef] [PubMed] [Google Scholar]
  • Rolling T, Wichmann D, Schmiedel S, Burchard GD, Kluge S, Cramer JP (2013) Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis. Malar J 12: 241 [CrossRef] [PubMed] [Google Scholar]
  • Marks ME, Armstrong M, Suvari MM, Batson S, Whitty CJM, Chiodini PL, Bellinghan G, Doherty JF, (2013) Severe imported falciparum malaria among adults requiring intensive care: a retrospective study at the hospital for tropical diseases. London BMC Infect Dis 13: 118 [CrossRef] [Google Scholar]
  • Santos LC, Abreu CF, Xerinda SM, Tavares M, Lucas R, Sarmento AC, (2012) Severe imported malaria in an intensive care unit: a review of 59 cases. Malar J 11: 96 [CrossRef] [PubMed] [Google Scholar]
  • Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, Danis M, Fontanet A, Durand R, French National Reference Centers for Imported and Autochthonous Malaria Epidemiology and Chemosensitivity Network, (2007) Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis 13: 883–888 [CrossRef] [PubMed] [Google Scholar]
  • Twomey PS, Smith BL, McDermott C, Novitt-Moreno A, McCarthy W, Kachur SP, Arguin PM, (2015) Intravenous artesunate for the treatment of severe and complicated malaria in the United States: clinical use under an investigational new drug protocol. Ann Intern Med 163: 498–506 [CrossRef] [PubMed] [Google Scholar]
  • Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E; French Artesunate Working Group, (2015) Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011–2013. Emerg Infect Dis 21: 804–812 [CrossRef] [PubMed] [Google Scholar]
  • Marks M, Armstrong M, Walker D, Doherty T, (2014) Imported falciparum malaria among adults requiring intensive care: analysis of the literature. Malar J 13: 79 [CrossRef] [PubMed] [Google Scholar]
  • Seringe E, Thellier M, Fontanet A, Legros F, Bouchaud O, Ancelle T, Kendjo E, Houze S, Le Bras J, Danis M, Durand R; French National Reference Center for Imported Malaria Study Group, (2011) Severe imported Plasmodium falciparum malaria, France, 1996–2003. Emerg Infect Dis 17: 807–813 [CrossRef] [PubMed] [Google Scholar]
  • Khuu D, Eberhard ML, Bristow BN, Javanbakht M, Ash LR, Shafir SC, Sorvillo FJ, (2017) Malaria-related hospitalizations in the United States, 2000–2014. Am J Trop Med Hyg 97: 213–221 [CrossRef] [PubMed] [Google Scholar]
  • Wyss K, Wångdahl A, Vesterlund M, Hammar U, Dashti S, Naucler P, Färnert A, (2017) Obesity and diabetes as risk factors for severe Plasmodium falciparum malaria: results from a Swedish nationwide study. Clin Infect Dis 65: 949–958 [CrossRef] [PubMed] [Google Scholar]
  • Askling HH, Bruneel F, Burchard G, Castelli F, Chiodini PL, Grobusch MP, Lopez-Vélez R, Paul M, Petersen E, Popescu C, Ramharter M, Schlagenhauf P; European Society for Clinical Microbiology and Infectious Diseases Study Group on Clinical Parasitology, (2012) Management of imported malaria in Europe. Malar J 11: 328 [CrossRef] [PubMed] [Google Scholar]
  • Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, Deutschman CS, Escobar GJ, Angus DC, (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315: 762–774 [CrossRef] [PubMed] [Google Scholar]
  • White NJ, (1997) Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 41: 1413 [PubMed] [Google Scholar]
  • Miller RS, Li Q, Cantilena LR, Leary KJ, Saviolakis GA, Melendez V, Smith B, Weina PJ, (2012) Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b study. Malar J 11: 255 [CrossRef] [PubMed] [Google Scholar]
  • Sinclair D, Donegan S, Isba R, Lalloo DG, (2012) Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev: CD005967 [Google Scholar]
  • Dondorp A, Nosten F, Stepniewska K, Day N, White N, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) Group, (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366: 717–725 [CrossRef] [PubMed] [Google Scholar]
  • Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ; AQUAMAT group, (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376: 1647–1657 [CrossRef] [PubMed] [Google Scholar]
  • Efferth T, Kaina B, (2010) Toxicity of the antimalarial artemisinin and its dervatives. Crit Rev Toxicol 40: 405–421 [CrossRef] [PubMed] [Google Scholar]
  • Rosenthal PJ, (2008) Artesunate for the treatment of severe falciparum malaria. N Engl J Med 358: 1829–1836 [CrossRef] [PubMed] [Google Scholar]
  • HCSP, (2013) Avis relatif à la place de l’artésunate injectable dans le traitement du paludisme grave chez l’adulte et l’enfant [Internet]. [cited 2017 Aug 23]. Available from: http://www. hcsp.fr/explore.cgi/telecharger/hcspa20130201_palugraveartesunate. pdf [Google Scholar]
  • Giao PT, Binh TQ, Kager PA, Long HP, Van Thang N, Van Nam N, de Vries PJ, (2001) Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? Am J Trop Med Hyg 65: 690–695 [CrossRef] [PubMed] [Google Scholar]
  • Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ, Tracking Resistance to Artemisinin Collaboration (TRAC), (2014) Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371: 411–423 [CrossRef] [PubMed] [Google Scholar]
  • Lu F, Culleton R, Zhang M, Ramaprasad A, von Seidlein L, Zhou H, Zhu G, Tang J, Liu Y, Wang W, Cao Y, Xu S, Gu Y, Li J, Zhang C, Gao Q, Menard D, Pain A, Yang H, Zhang Q, Cao J, (2017) Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa. N Engl J Med 376: 991–993 [Google Scholar]
  • Maude RJ, Barkhof F, Hassan MU, Ghose A, Hossain A, Abul Faiz M, Choudhury E, Rashid R, Abu Sayeed A, Charunwatthana P, Plewes K, Kingston H, Maude RR, Silamut K, Day NP, White NJ, Dondorp AM, (2014) Magnetic resonance imaging of the brain in adults with severe falciparum malaria. Malar J 13:177 [CrossRef] [PubMed] [Google Scholar]
  • Seydel KB, Kampondeni SD, Valim C, Potchen MJ, Milner DA, Muwalo FW, Birbeck GL, Bradley WG, Fox LL, Glover SJ, Hammond CA, Heyderman RS, Chilingulo CA, Molyneux ME, Taylor TE, (2015) Brain swelling and death in children with cerebral malaria. N Engl J Med 372: 1126–1137 [CrossRef] [PubMed] [Google Scholar]
  • Potchen MJ, Kampondeni SD, Seydel KB, Birbeck GL, Hammond CA, Bradley WG, DeMarco JK, Glover SJ, Ugorji JO, Latourette MT, Siebert JE, Molyneux ME, Taylor TE, (2012) Acute brain MRI findings in 120 Malawian children with cerebral malaria: new insights into an ancient disease. AJNR Am J Neuroradiol 33: 1740–1746 [CrossRef] [PubMed] [Google Scholar]
  • Laurent V, Bruneel F, (2017) Neuropaludisme : de la physiopathologie à la clinique. Lettre du Neurologue XXI: 152–157 [Google Scholar]
  • Maude RJ, Beare NAV, Abu Sayeed A, Chang CC, Charunwatthana P, Faiz MA, Hossain A, Yunus EB, Hoque MG, Hasan MU, White NJ, Day NP, Dondorp AM, (2009) The spectrum of retinopathy in adults with Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 103: 665–671 [CrossRef] [PubMed] [Google Scholar]
  • Abu Sayeed A, Maude RJ, Hasan MU, Mohammed N, Hoque MG, Dondorp AM, Faiz MA, (2011) Malarial retinopathy in Bangladeshi adults. Am J Trop Med Hyg 84: 141–147 [CrossRef] [PubMed] [Google Scholar]
  • Crawley J, Waruiru C, Mithwani S, Mwangi I, Watkins W, Ouma D, Winstanley P, Peto T, Marsh K, (2000) Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet 355: 701–706 [CrossRef] [PubMed] [Google Scholar]
  • Hanson J, Lam SWK, Mahanta KC, Pattnaik R, Alam S, Mohanty S, Hasan MU, Hossain A, Charunwatthana P, Chotivanich K, Maude RJ, Kingston H, Day NP, Mishra S, White NJ, Dondorp AM (2012) Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria. J Infect Dis 206: 571–579 [CrossRef] [PubMed] [Google Scholar]
  • Hanson J, Lam SWK, Alam S, Pattnaik R, Mahanta KC, Uddin Hasan M, Mohanty S, Mishra S, Cohen S, Day N, White N, Dondorp A, (2013) The reliability of the physical examination to guide fluid therapy in adults with severe falciparum malaria: an observational study. Malar J 12: 348 [CrossRef] [PubMed] [Google Scholar]
  • Hanson JP, Lam SWK, Mohanty S, Alam S, Pattnaik R, Mahanta KC, Hasan MU, Charunwatthana P, Mishra SK, Day NP, White NJ, Dondorp AM, (2013) Fluid resuscitation of adults with severe falciparum malaria: effects on Acid-base status, renal function, and extravascular lung water. Crit Care Med 41: 972–981 [CrossRef] [PubMed] [Google Scholar]
  • Bruneel F, Gachot B, Timsit JF, Wolff M, Bédos JP, Régnier B, Vachon F, (1997) Shock complicating severe falciparum malaria in European adults. Intensive Care Med 23: 698–701 [CrossRef] [PubMed] [Google Scholar]
  • Herr J, Mehrfar P, Schmiedel S, Wichmann D, Brattig NW, Burchard GD, Cramer JP, (2011) Reduced cardiac output in imported Plasmodium falciparum malaria. Malar J 10: 160 [CrossRef] [PubMed] [Google Scholar]
  • Taylor WRJ, Hanson J, Turner GDH, White NJ, Dondorp AM, (2012) Respiratory manifestations of malaria. Chest 142: 492–505 [CrossRef] [PubMed] [Google Scholar]
  • Matthay MA, McAuley DF, Ware LB, (2017) Clinical trials in acute respiratory distress syndrome: challenges and opportunities. Lancet Respir Med 5: 524–534 [Google Scholar]
  • Alves C, Chen JT, Patel N, Abrams D, Figueiredo P, Santos L, Sarmento A, Paiva JA, Bacchetta M, Wilgus ML, Roncon-Albuquerque R Jr, Brodie D, (2013) Extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome in severe malaria. Malar J 12: 306 [CrossRef] [PubMed] [Google Scholar]
  • Riddle MS, Jackson JL, Sanders JW, Blazes DL, (2002) Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis 34: 1192–1198 [CrossRef] [PubMed] [Google Scholar]
  • Tan KR, Wiegand RE, Arguin PM, (2013) Exchange transfusion for severe malaria: evidence base and literature review. Clin Infect Dis 57: 923–928 [CrossRef] [PubMed] [Google Scholar]
  • John CC, Kutamba E, Mugarura K, Opoka RO, (2010) Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther 8: 997–1008 [CrossRef] [PubMed] [Google Scholar]
  • Higgins SJ, Kain KC, Liles WC, (2011) Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria. Expert Rev Anti Infect Ther 9: 803–819 [CrossRef] [PubMed] [Google Scholar]
  • Brooks HM, Hawkes MT, (2017) Repurposing pharmaceuticals as neuroprotective agents for cerebral malaria. Curr Clin Pharmacol 12: 62–72 [ahead of print] [CrossRef] [PubMed] [Google Scholar]
  • Villarino NF, LeCleir GR, Denny JE, Dearth SP, Harding CL, Sloan SS, Gribble JL, Campagna SR, Wilhelm SW, Schmidt NW, (2016) Composition of the gut microbiota modulates the severity of malaria. Proc Natl Acad Sci U S A 113: 2235–2240 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.